In connection with the implementation of the project entitled “Design and development of nanoparticle -RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nuclear acids ” by Biotechna SA under contract no. 2022/ABM/06/00005-00 for co-financing a commercial project as part of the Competition for the development of targeted or personalized medicine based on medicinal products based on nucleic acids and small-molecule compounds. The Ordering Party carries out market research regarding the costs of purchase and delivery columns for purification of DNA/RNA oligonucleotides using the reverse phase (RP) method.
To submit a offer, please review the detailed terms of the notice contained in Request for Quotation No. 42/2026 and submit the completed offer form along with the product range and price list.